STOCK TITAN

Mason Capital discloses 5.8% Veradigm (MDRX) stake in Schedule 13G

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

Mason Capital Management LLC and its principals have disclosed a significant passive stake in Veradigm Inc. They report beneficial ownership of 6,283,161 shares of Veradigm common stock, representing 5.8% of the outstanding shares, as of an event dated 01/22/2026.

The ownership is held through Mason Capital Master Fund, L.P., over which Mason Capital Management has voting and investment discretion. Managing principals Kenneth M. Garschina and Michael E. Martino are reported as sharing voting and dispositive power over the same shares. The percentage is based on 108,900,000 Veradigm shares outstanding as of September 29, 2025.

The reporting persons certify that the securities were not acquired and are not held for the purpose of changing or influencing control of Veradigm, consistent with a passive investment reported on Schedule 13G.

Positive

  • None.

Negative

  • None.





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Mason Capital Management LLC
Signature:/s/ John Grizzetti
Name/Title:John Grizzetti, Chief Operating Officer
Date:01/29/2026
Kenneth M. Garschina
Signature:/s/ Kenneth M. Garschina
Name/Title:Kenneth M. Garschina, Individually
Date:01/29/2026
Michael E. Martino
Signature:/s/ Michael E. Martino
Name/Title:Michael E. Martino, Individually
Date:01/29/2026
Exhibit Information

Exhibit 99.1: Joint Filing Agreement

FAQ

What does Mason Capital’s Schedule 13G filing reveal about Veradigm (MDRX)?

The filing shows Mason Capital-related entities beneficially own 6,283,161 Veradigm shares, or 5.8% of the common stock. This stake is held through Mason Capital Master Fund, with shared voting and dispositive power among Mason Capital Management and its managing principals.

How large is Mason Capital’s ownership stake in Veradigm (MDRX)?

Mason Capital reports beneficial ownership of 6,283,161 Veradigm common shares, representing 5.8% of the company’s outstanding stock. The percentage is calculated using 108,900,000 shares outstanding as of September 29, 2025, as referenced from a prior Veradigm disclosure.

Who are the reporting persons in the Veradigm (MDRX) Schedule 13G filing?

The reporting persons are Mason Capital Management LLC, and individuals Kenneth M. Garschina and Michael E. Martino. The shares are directly held by Mason Capital Master Fund, L.P., for which Mason Capital Management acts as investment manager and Garschina and Martino are managing principals.

Is Mason Capital’s Veradigm (MDRX) stake reported as passive or activist?

The stake is reported as passive. The reporting persons certify the Veradigm securities were not acquired and are not held to change or influence control of the issuer, aligning with the passive ownership framework associated with a Schedule 13G filing.

What voting and dispositive powers are reported over Veradigm (MDRX) shares?

Each reporting person lists zero sole voting and dispositive power, and 6,283,161 shares under shared voting and shared dispositive power. This reflects coordinated authority over how the Veradigm shares held by Mason Capital Master Fund may be voted and disposed of.

How was the 5.8% Veradigm (MDRX) ownership percentage calculated?

The 5.8% figure is based on 6,283,161 Veradigm shares reported as beneficially owned, divided by 108,900,000 shares outstanding. The outstanding share count comes from Veradigm’s Form 8-K exhibit dated September 30, 2025, as cited in the ownership section.
Veradigm

OTC:MDRX

MDRX Rankings

MDRX Latest News

MDRX Latest SEC Filings

MDRX Stock Data

499.56M
103.82M
4.28%
41.94%
Health Information Services
Healthcare
Link
United States
Chicago